Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection

Like other organs, brain functions diminish with age. Furthermore, for a variety of neurological disorders—including Alzheimer’s disease—age is one of the higher-risk factors. Since in many Western countries the average age is increasing, determining approaches for decreasing the effects of aging on...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Osama Elsallabi, Antonia Patruno, Mirko Pesce, Amelia Cataldi, Simone Carradori, Marialucia Gallorini
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-01-01
Colecção:	Molecules
Assuntos:	fisetin senescence neuroinflammation neuroprotection senolytic drug in silico evaluation
Acesso em linha:	https://www.mdpi.com/1420-3049/27/3/738
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!